Regen Biopharma Inc (PK) (RGBPP) Fundamentals

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at
Share Info
Market Cap$ 20,954,295
Shares Authorized540,000,000
Shares Outstanding439,293,406
Shares Outstanding Date08/03/2022
Shareholder Count467
Shareholder Count Date12/27/2018
Float Date02/11/2019
Short Interest3,620
Short Interest Date07/15/2022
Reporting Info
Reporting StatusSEC Reporting
Audit StatusYes
AuditorBF Borgers CPA PC
Auditor Address5400 West Cedar Avenue
Lakewood, Colorado 80226
Auditor Website
IR Firm-
IR Firm Address-
IR Firm Website-
Legal Counsel-
Legal Counsel Address-
Legal Counsel Website-
Fiscal Year End9/30
ADR Ratio-
Transfer AgentNevada Agency and Transfer Company
Transfer Agent Address50 W. Liberty St.
Suite 880
Reno, NV 89501
Depository Website
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:RGBPP
OTC Market TierPink Current
Security TypePreferred Stock
CIK Number0001589150
Address4700 Spring Street
St 304
La Mesa, California 91942
Phone(619) 722 5505
Fax #619 330 2328
SIC Code / Description2834 / Pharmaceutical preparations
Key ExecutivesCEO - David Koos
CEO - David Koos
Number of Employees4
Incorporation StateNevada
Incorporation CountryUSA
Incorporation Year2012

Your Recent History
Regen Biop..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.